Mandate

Vinge advises NatWest Markets in connection with a securitisation of secured SME loans

May 19, 2021 Banking and Finance

Vinge has acted for NatWest Markets N.V. as senior lender in the structuring, documenting and execution of a securitisation of secured loans to small and medium sized enterprises (SMEs) granted by DBT Capital AB and its subsidiary (”DBT”), in cooperation with, amongst others, the management of DBT and DBT’s legal advisor. In connection with the securitisation, DBT entered into an up to SEK 1,000,000,000 financing agreement with NatWest Markets as senior lender.

DBT is a Swedish private lender registered with the Swedish Financial Supervisory Authority and who offers corporate loans and financing to SMEs in Sweden.

The transaction is executed and reported under the EU securitisation regulation (Regulation (EU) 2017/2402 of the European Parliament and of the Council of 12 December 2017) and is subject to the reporting requirements thereunder.

Vinge’s team consisted primarily of responsible partner Albert Wållgren together with associates Lionardo Ojeda, Paulina Malmberg, Seyran Sahin, Axel Jansson, Elin Samara and Rebecka Målquist.

Related

Vinge advises Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of Bizware

Vinge has advised the Nordic private equity firm Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of the data analytics and AI firm Bizware AB and its subsidiaries Bizware Lead AB and Bizware Nova AB.
September 11, 2025

Vinge has acted as local counsel supporting lead counsel Latham & Watkins in advising Cadence in connection with its acquisition of Hexagon’s Design & Engineering Business for approx. EUR 2.7 billion

Cadence (Nasdaq: CDNS) announced it has entered into a definitive agreement to acquire the Design & Engineering business of Hexagon AB, which includes its MSC Software business—a pioneer in engineering simulation and analysis solutions.
September 09, 2025

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025